Security Risks Around Super Bowl LX: What Security Leaders Should Be Watching
The Super Bowl is not just a game, but a blueprint for how modern risk must be managed. Continue reading →
Agomab, SpyGlass bank a combined $350M in biotech IPOs
The two offerings capped off the busiest week for new biotech stock issuances in a year. Continue reading →
Earnings roundup: AbbVie angst, a bifurcated vaccine market and Bristol Myers’ waiting game
Vaccine makers are seeing sales declines in the U.S. and upswings in Europe. Elsewhere, investors fretted over an AbbVie franchise and Bristol Myers pointed to a trio of narrative-changing trials. Continue reading →
Novo, Lilly sputter as Hims launches knockoff GLP-1 pill
Novo is threatening litigation in response, while FDA head Martin Makary, without naming specific companies, said the agency would take “swift action” against those “mass-marketing illegal copycat drugs.” Continue reading →
Effective but Underprescribed: HIV Prevention Meds Aren’t Reaching Enough People
Listen: More than 2 million Americans could benefit from PrEP, but only about a quarter of them are getting the HIV prevention medication. On Feb. 4, during WAMU’s “Health Hub,” KFF Health News reporter Zach Dyer shared tips for overcoming common hurdles to care. Billing...
Ciara Brings Lingerie Inspiration to NFL Honors Red Carpet in Valdrin Sahiti
The singer attended the NFL Honors on Thursday night. Continue reading →
CFDA/Genesis AAPI Design + Innovation Grant Awarded to Terrence Zhou of Bad Binch TongTong
Zhou will receive total grant funding of $100,000. Continue reading →
Under Armour Beats Projections in Q3 Despite Continuing Weakness in North America
The Baltimore-based sports brand also raised its outlook for fiscal 2026. Continue reading →
Test yourself on the past week’s K-12 news
From the Education Department’s FY 2026 budget to ransomware attacks on schools and colleges, what did you learn from our recent stories? Continue reading →